NCT00009204View on ClinicalTrials.gov

Serotonergic Pharmacotherapy for Agitation of Dementia

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

September 30, 1995

Primary Completion Date

April 30, 2000

Study Completion Date

April 30, 2002

Conditions
DementiaAlzheimer DiseaseDementia, Vascular
Interventions
DRUG

Citalopram [Celexa]

DRUG

Perphenazine [Trilafon]

Trial Locations (1)

15213

University of Pittsburgh Western Psychiatric Institute and Clinic, Pittsburgh

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Bruce Pollock

OTHER

NCT00009204 - Serotonergic Pharmacotherapy for Agitation of Dementia | Biotech Hunter | Biotech Hunter